Endofluke fluckicide approved for use in dairy

Endofluke 100mg Oral Suspension has now been approved for use in dairy cows, with a milk withdrawal period of 47 days.

Endofluke is licensed for use in cattle and sheep and its active ingredient, triclabendazole (100mg/ml), is the only active proven to kill all three stages of liver fluke.

Bimeda UK Sales Manager, Andrew Lane, commented: “This is great news for the UK’s dairy farmers. It is proven to be highly effective against early-immature, immature and adult liver fluke, and to now be able to extend these benefits to dairy cows, is fantastic news for the UK’s dairy farmers.”

Advice should be sought from the medicines prescriber before using the product.

For more information, see www.bimeda.co.uk